97 related articles for article (PubMed ID: 9368282)
41. [Predictive tests for familial medullary cancer of the thyroid].
Lenoir GM; Sobol H
Pathol Biol (Paris); 1992 Nov; 39(9):921-2. PubMed ID: 1538934
[No Abstract] [Full Text] [Related]
42. Oncogenes in thyroid cancer.
Kim DS; McCabe CJ; Buchanan MA; Watkinson JC
Clin Otolaryngol Allied Sci; 2003 Oct; 28(5):386-95. PubMed ID: 12969338
[TBL] [Abstract][Full Text] [Related]
43. Molecular targeted therapy for thyroid cancer in Japan: a call to reduce the backlog.
Yamashita S
Endocr J; 2009; 56(8):919-20. PubMed ID: 19952465
[No Abstract] [Full Text] [Related]
44. Molecular genetics of thyroid cancer.
Wynford-Thomas D
Trends Endocrinol Metab; 1993 Sep; 4(7):224-32. PubMed ID: 18407160
[TBL] [Abstract][Full Text] [Related]
45. [Progress in research of thyroid carcinoma related gene mutation and epigenetics].
Zheng WH; Gong WW; Lu F; Yu M
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Nov; 38(11):1579-1583. PubMed ID: 29141353
[TBL] [Abstract][Full Text] [Related]
46. Genetic instability in fibroblasts of patients with thyroid cancers (TC).
Krizman DB; Pathak S; Samaan NA; Hickey RC
Int J Cancer; 1987 Feb; 39(2):179-81. PubMed ID: 3804492
[TBL] [Abstract][Full Text] [Related]
47. Molecular signaling in thyroid cancer.
Sarlis NJ; Benvenga S
Cancer Treat Res; 2004; 122():237-64. PubMed ID: 16209049
[No Abstract] [Full Text] [Related]
48. Editorial: Translational research in thyroid cancer, Volume II.
Cheng SY; Vasko V; Jensen KE
Front Endocrinol (Lausanne); 2023; 14():1223976. PubMed ID: 37383388
[No Abstract] [Full Text] [Related]
49. Thyroid cancer overdiagnosis: Implications for understanding radiation carcinogenesis and for medical imaging.
Socol Y; Shaki YY; Vaiserman A
Chem Biol Interact; 2019 May; 305():1-2. PubMed ID: 30914236
[No Abstract] [Full Text] [Related]
50. Rethinking the role of oncogenes in papillary thyroid cancer initiation.
Vitale M
Front Endocrinol (Lausanne); 2012; 3():83. PubMed ID: 22740838
[No Abstract] [Full Text] [Related]
51. Discussion.
J Am Coll Surg; 2017 Jul; 225(1):136-137. PubMed ID: 28648339
[No Abstract] [Full Text] [Related]
52. Microarray analysis of molecules expressed during radiation-induced rat thyroid carcinogenesis.
Wang Y; Yue C; Yu Q; Yan L
J Radiat Res; 2021 Oct; ():. PubMed ID: 34632518
[No Abstract] [Full Text] [Related]
53. Oncogenes and thyroid tumors: Scratching the surface.
Low MJ
Endocr Pathol; 1991 Sep; 2(3):120-122. PubMed ID: 32357639
[No Abstract] [Full Text] [Related]
54. [Medullary thyroid carcinoma and some of its particularities].
Sidibé el H
Sante; 2007; 17(1):51-5. PubMed ID: 17897902
[TBL] [Abstract][Full Text] [Related]
55. [Thyroid carcinoma].
Namba H; Izumi M
Gan To Kagaku Ryoho; 1991 Jan; 18(1):22-9. PubMed ID: 1987898
[TBL] [Abstract][Full Text] [Related]
56. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
[TBL] [Abstract][Full Text] [Related]
57. Multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma: Turkish experience.
Erdogan MF; Gursoy A
Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():503-7. PubMed ID: 17551473
[TBL] [Abstract][Full Text] [Related]
58. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
59. An overview of molecular abnormalities leading to thyroid carcinogenesis: a 1993 perspective.
Gagel RF
Stem Cells; 1997; 15 Suppl 2():7-13. PubMed ID: 9368282
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
